Skip to main content
Top
Published in: Diabetology International 3/2022

17-02-2022 | Obesity | Original Article

Eighteen-year trends in the management of patients with diabetes in the Shiga Diabetes Clinical Survey: overall trends and differences by age group

Authors: Itsuko Miyazawa, Hiroshi Maegawa, Aya Kadota, Takashi Nakamura, Makoto Konishi, Shinichi Ochi, Katsuyuki Miura, Motozumi Okamoto, for the Shiga Diabetes Clinical Survey

Published in: Diabetology International | Issue 3/2022

Login to get access

Abstract

Aim

To examine the trends in the management of patients with diabetes over an 18-year period in Japan.

Participants and methods

We recorded the height, body mass, laboratory data, diabetes treatment, and screening status of diabetic complications from the data collected during the Shiga Diabetes Clinical Survey, which has been performed every 6 years since 2000. We then evaluated the management of patients with diabetes in Shiga Prefecture. The study included 17,870, 18,398, 24,243, and 26,624 participants in each of the 4 years of measurements.

Results

The mean age and body mass index (BMI) of the participants gradually increased. The percentage of patients with BMI of ≥ 25 kg/m2 was higher in younger patients. Glycemic control significantly improved over 18 years (hemoglobin A1c: 7.3% ± 1.4% in 2000 to 7.1% ± 1.1% in 2018, P for trend < 0.001). The mean hemoglobin A1c levels were higher in younger patients than in elderly patients and increased from 2012 to 2018 in patients aged ≥ 65 years. The proportion of participants who underwent screening for albuminuria and diabetic retinopathy increased. The mean blood pressure and low-density lipoprotein cholesterol concentration decreased.

Conclusions

Glycemic control has been maintained at an acceptable level since the previous survey. Although glycemic control has become less strict in elderly patients with diabetes, glycemic control is poorer in younger patients than in elderly patients. Obesity is an increasingly important problem, particularly in younger patients. The frequency of screening for diabetic complications and the control of blood pressure should be improved.
Appendix
Available only for authorised users
Literature
1.
go back to reference International Diabetes Federation. IDF diabetes atlas. 9th ed. 2019. p. 34–61. International Diabetes Federation. IDF diabetes atlas. 9th ed. 2019. p. 34–61.
4.
go back to reference Morizane Y, Morimoto N, Fujiwara A, Kawasaki R, Yamashita H, Ogura Y, et al. Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol. 2019;63(1):26–33.CrossRef Morizane Y, Morimoto N, Fujiwara A, Kawasaki R, Yamashita H, Ogura Y, et al. Incidence and causes of visual impairment in Japan: the first nation-wide complete enumeration survey of newly certified visually impaired individuals. Jpn J Ophthalmol. 2019;63(1):26–33.CrossRef
6.
go back to reference Tajima N, Nishimura R, Izumi K, Hayashino Y, Origasa H, Noda M, et al. A large-scale, observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 2 diabetes—JDCP study 1. Diabetol Int. 2015;6(4):243–51.CrossRef Tajima N, Nishimura R, Izumi K, Hayashino Y, Origasa H, Noda M, et al. A large-scale, observational study to investigate the current status of diabetes complications and their prevention in Japan: research outline and baseline data for type 2 diabetes—JDCP study 1. Diabetol Int. 2015;6(4):243–51.CrossRef
7.
go back to reference Sugiyama T, Miyo K, Tsujimoto T, Kominami R, Ohtsu H, Ohsugi M, et al. Design of and rationale for the Japan Diabetes comprehensive database project based on an advanced electronic medical record system (J-DREAMS). Diabetol Int. 2017;8(4):375–82.CrossRef Sugiyama T, Miyo K, Tsujimoto T, Kominami R, Ohtsu H, Ohsugi M, et al. Design of and rationale for the Japan Diabetes comprehensive database project based on an advanced electronic medical record system (J-DREAMS). Diabetol Int. 2017;8(4):375–82.CrossRef
9.
go back to reference Miyazawa I, Kadota A, Okamoto M, Miura K, Maegawa H, Ohnishi A, et al. Trends in medical performance in diabetic patients in primary care clinics compared with those in hospitals: Shiga Diabetes Clinical Survey, Japan, 2000–2012. Diabetol Int. 2017;8:59–68.CrossRef Miyazawa I, Kadota A, Okamoto M, Miura K, Maegawa H, Ohnishi A, et al. Trends in medical performance in diabetic patients in primary care clinics compared with those in hospitals: Shiga Diabetes Clinical Survey, Japan, 2000–2012. Diabetol Int. 2017;8:59–68.CrossRef
10.
go back to reference Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig. 2012;3(1):39–40.CrossRef Kashiwagi A, Kasuga M, Araki E, Oka Y, Hanafusa T, Ito H, et al. International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values. J Diabetes Investig. 2012;3(1):39–40.CrossRef
11.
go back to reference Japan Diabetes Society. Japanese clinical practice guideline for diabetes 2019. Nankodo. 2019. p. 245–260. Japan Diabetes Society. Japanese clinical practice guideline for diabetes 2019. Nankodo. 2019. p. 245–260.
12.
go back to reference Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174(2):251–8.CrossRef Huang ES, Laiteerapong N, Liu JY, John PM, Moffet HH, Karter AJ. Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study. JAMA Intern Med. 2014;174(2):251–8.CrossRef
13.
go back to reference Fukumoto YOM, Arai K, Yagi N, Shirabe S, Sugimoto H, Okuguchi F, Maegawa H. Japan Diabetes Clinical Data Management Study Group. Clinical characteristics and treatment of patients with diabetes mellitus over 60 years of age (cross-sectional survey with JDDM data). J Jpn Diab Soc. 2020;63(4):8. Fukumoto YOM, Arai K, Yagi N, Shirabe S, Sugimoto H, Okuguchi F, Maegawa H. Japan Diabetes Clinical Data Management Study Group. Clinical characteristics and treatment of patients with diabetes mellitus over 60 years of age (cross-sectional survey with JDDM data). J Jpn Diab Soc. 2020;63(4):8.
14.
go back to reference Japan Diabetes Society/Japan Geriatrics Society Joint Committee on Improving Care for Elderly Patients with D, Haneda M, Ito H. Glycemic targets for elderly patients with diabetes. Diabetol Int. 2016;7(4):331–3.CrossRef Japan Diabetes Society/Japan Geriatrics Society Joint Committee on Improving Care for Elderly Patients with D, Haneda M, Ito H. Glycemic targets for elderly patients with diabetes. Diabetol Int. 2016;7(4):331–3.CrossRef
17.
go back to reference Fang M, Selvin E. Thirty-year trends in complications in U.S. adults with newly diagnosed type 2 diabetes. Diabetes Care. 2021;44(3):699–706.CrossRef Fang M, Selvin E. Thirty-year trends in complications in U.S. adults with newly diagnosed type 2 diabetes. Diabetes Care. 2021;44(3):699–706.CrossRef
18.
go back to reference Miyazawa I, Kadota A, Miura K, Okamoto M, Nakamura T, Ikai T, et al. Twelve-year trends of increasing overweight and obesity in patients with diabetes: the Shiga Diabetes Clinical Survey. Endocr J. 2018;65(5):527–36.CrossRef Miyazawa I, Kadota A, Miura K, Okamoto M, Nakamura T, Ikai T, et al. Twelve-year trends of increasing overweight and obesity in patients with diabetes: the Shiga Diabetes Clinical Survey. Endocr J. 2018;65(5):527–36.CrossRef
19.
go back to reference Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, et al. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care. 2016;4(1): e000294.CrossRef Yokoyama H, Oishi M, Takamura H, Yamasaki K, Shirabe SI, Uchida D, et al. Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40). BMJ Open Diabetes Res Care. 2016;4(1): e000294.CrossRef
20.
go back to reference Inoue H, Morino K, Ugi S, Tanaka-Mizuno S, Fuse K, Miyazawa I, et al. Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: a randomized clinical trial. J Diabetes Investig. 2019;10(4):1012–21.CrossRef Inoue H, Morino K, Ugi S, Tanaka-Mizuno S, Fuse K, Miyazawa I, et al. Ipragliflozin, a sodium-glucose cotransporter 2 inhibitor, reduces bodyweight and fat mass, but not muscle mass, in Japanese type 2 diabetes patients treated with insulin: a randomized clinical trial. J Diabetes Investig. 2019;10(4):1012–21.CrossRef
21.
go back to reference Sugiyama T, Imai K, Ihana-Sugiyama N, Tanaka H, Yanagisawa-Sugita A, Sasako T, et al. Variation in process quality measures of diabetes care by region and institution in Japan during 2015–2016: an observational study of nationwide claims data. Diabetes Res Clin Pract. 2019;155: 107750.CrossRef Sugiyama T, Imai K, Ihana-Sugiyama N, Tanaka H, Yanagisawa-Sugita A, Sasako T, et al. Variation in process quality measures of diabetes care by region and institution in Japan during 2015–2016: an observational study of nationwide claims data. Diabetes Res Clin Pract. 2019;155: 107750.CrossRef
23.
go back to reference Moreton RBR, Stratton IM, Chave SJ, Lipinski H, Scanlon PH. Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabet Med. 2017;34(7):993–9.CrossRef Moreton RBR, Stratton IM, Chave SJ, Lipinski H, Scanlon PH. Factors determining uptake of diabetic retinopathy screening in Oxfordshire. Diabet Med. 2017;34(7):993–9.CrossRef
24.
go back to reference Kelly SR, Loiselle AR, Pandey R, Combes A, Murphy C, Kavanagh H, et al. Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2). Acta Diabetol. 2021;58(5):643–50.CrossRef Kelly SR, Loiselle AR, Pandey R, Combes A, Murphy C, Kavanagh H, et al. Factors associated with non-attendance in the Irish national diabetic retinopathy screening programme (INDEAR study report no. 2). Acta Diabetol. 2021;58(5):643–50.CrossRef
25.
go back to reference Sachdeva A, Stratton IM, Unwin J, Moreton R, Scanlon PH. Diabetic retinopathy screening: study to determine risk factors for non-attendance. Diabetes Primary Care. 2012;14(5):9. Sachdeva A, Stratton IM, Unwin J, Moreton R, Scanlon PH. Diabetic retinopathy screening: study to determine risk factors for non-attendance. Diabetes Primary Care. 2012;14(5):9.
26.
go back to reference Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care. 2008;31(11):2131–5.CrossRef Leese GP, Boyle P, Feng Z, Emslie-Smith A, Ellis JD. Screening uptake in a well-established diabetic retinopathy screening program: the role of geographical access and deprivation. Diabetes Care. 2008;31(11):2131–5.CrossRef
27.
go back to reference Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412–8.CrossRef Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, et al. Diabetic retinopathy: a position statement by the American Diabetes Association. Diabetes Care. 2017;40(3):412–8.CrossRef
28.
go back to reference Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.CrossRef Harding JL, Pavkov ME, Magliano DJ, Shaw JE, Gregg EW. Global trends in diabetes complications: a review of current evidence. Diabetologia. 2019;62(1):3–16.CrossRef
29.
go back to reference Luk AOY, Hui EMT, Sin MC, Yeung CY, Chow WS, Ho AYY, et al. Declining trends of cardiovascular-renal complications and mortality in type 2 diabetes: the Hong Kong Diabetes Database. Diabetes Care. 2017;40(7):928–35.CrossRef Luk AOY, Hui EMT, Sin MC, Yeung CY, Chow WS, Ho AYY, et al. Declining trends of cardiovascular-renal complications and mortality in type 2 diabetes: the Hong Kong Diabetes Database. Diabetes Care. 2017;40(7):928–35.CrossRef
30.
go back to reference Yokoyama H, Araki SI, Kawai K, Yamazaki K, Tomonaga O, Shirabe SI, et al. Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46). BMJ Open Diabetes Res Care. 2018;6(1): e000521.CrossRef Yokoyama H, Araki SI, Kawai K, Yamazaki K, Tomonaga O, Shirabe SI, et al. Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46). BMJ Open Diabetes Res Care. 2018;6(1): e000521.CrossRef
31.
go back to reference Yokoyama H, Araki SI, Kawai K, Hirao K, Kurihara Y, Seino H, et al. Current status of achieving blood pressure target and its clinical correlates in Japanese type 2 diabetes. J Diabetes Investig. 2017;9(3):594–601.CrossRef Yokoyama H, Araki SI, Kawai K, Hirao K, Kurihara Y, Seino H, et al. Current status of achieving blood pressure target and its clinical correlates in Japanese type 2 diabetes. J Diabetes Investig. 2017;9(3):594–601.CrossRef
32.
go back to reference Ueki K, Sasako T, Okazaki Y, Miyake K, Nangaku M, Ohashi Y, et al. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021;99(1):256–66.CrossRef Ueki K, Sasako T, Okazaki Y, Miyake K, Nangaku M, Ohashi Y, et al. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021;99(1):256–66.CrossRef
33.
go back to reference Onda Y, Sugihara S, Ogata T, Yokoya S, Yokoyama T, Tajima N, et al. Incidence and prevalence of childhood-onset Type 1 diabetes in Japan: the T1D study. Diabet Med. 2016;34(7):909–15.CrossRef Onda Y, Sugihara S, Ogata T, Yokoya S, Yokoyama T, Tajima N, et al. Incidence and prevalence of childhood-onset Type 1 diabetes in Japan: the T1D study. Diabet Med. 2016;34(7):909–15.CrossRef
Metadata
Title
Eighteen-year trends in the management of patients with diabetes in the Shiga Diabetes Clinical Survey: overall trends and differences by age group
Authors
Itsuko Miyazawa
Hiroshi Maegawa
Aya Kadota
Takashi Nakamura
Makoto Konishi
Shinichi Ochi
Katsuyuki Miura
Motozumi Okamoto
for the Shiga Diabetes Clinical Survey
Publication date
17-02-2022
Publisher
Springer Nature Singapore
Published in
Diabetology International / Issue 3/2022
Print ISSN: 2190-1678
Electronic ISSN: 2190-1686
DOI
https://doi.org/10.1007/s13340-022-00573-2

Other articles of this Issue 3/2022

Diabetology International 3/2022 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine